Corticosterone methyl oxidase type II (CMO II) deficiency: biochemical approach to diagnosis.
Yong
A B
AB
Centre for Hormone Research, Royal Children's Hospital, Victoria, Australia.
Montalto
J
J
Pitt
J
J
Oakes
S
S
Preston
T
T
Buchanan
C
C
D015069:18-Hydroxycorticosterone / Q000031:analogs & derivatives / Q000097:blood* / Q000652:urine; D000450:Aldosterone / Q000097:blood; D019405:Cytochrome P-450 CYP11B2; D003937:Diagnosis, Differential; D005438:Fludrocortisone / Q000627:therapeutic use; D006801:Humans; D006908:Hydroxyprogesterones / Q000097:blood; D007223:Infant; D008297:Male; D008661:Metabolism, Inborn Errors / Q000097:blood* / Q000175:diagnosis* / Q000188:drug therapy; D006899:Mixed Function Oxygenases / Q000172:deficiency*; D012083:Renin / Q000097:blood
C092840:18-hydroxytetrahydrocorticosterone; D006908:Hydroxyprogesterones; D000450:Aldosterone; D015069:18-Hydroxycorticosterone; C027925:18-hydroxy-11-dehydrotetrahydrocorticosterone; D006899:Mixed Function Oxygenases; D019405:Cytochrome P-450 CYP11B2; C025352:corticosterone methyl oxidase II; D012083:Renin; D005438:Fludrocortisone